Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II

被引:60
作者
Chung, AS
Guan, YJ
Yuan, ZL
Albina, JE
Chin, YE [1 ]
机构
[1] Brown Univ, Sch Med, Dept Surg, Providence, RI 02903 USA
[2] Rhode Isl Hosp, Providence, RI 02903 USA
[3] Brown Univ, Sch Med, Dept Mol & Cell Biol, Providence, RI 02903 USA
[4] Brown Univ, Sch Med, Dept Biochem, Providence, RI 02903 USA
关键词
D O I
10.1128/MCB.25.11.4716-4726.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ankyrin repeat and SOCS box (ASB) family members have a C-terminal SOCS box and an N-terminal ankyrin-related sequence of variable repeats belonging to the SOCS superfamily. While SH2-domain-bearing SOCS proteins are mainly involved in the negative feedback regulation of the protein tyrosine kinase-STAT pathway in response to a variety of cytokines, the roles of ASB family members remain largely unknown. To investigate ASB functions, we screened for ASB3-interacting factors by using antibody array technology and identified tumor necrosis factor receptor II (TNF-R2) as an ASB3 binding target. ASB3 expression and activities are required for (i) TNF-R2 ubiquitination both in vivo and in vitro, (ii) TNF-R2 proteolysis via the proteasome pathway, and (iii) the inhibition of TNF-R2-mediated Jun N-terminal protein kinase (JNK) activation. While the ankyrin repeats of ASB3 interact with the C-terminal 37 amino acids of TNF-R2, the SOCS box of ASB3 is responsible for recruiting the E3 ubiquitin ligase adaptors Elongins-B/C, leading to TNF-R2 ubiquitination on multiple lysine residues within its C-terminal region. Downregulation of ASB3 expression by a small interfering RNA inhibited TNF-R2 degradation and potentiated TNF-R2-mediated cytotoxicity. The data presented here implicate ASB3 as a negative regulator of TNF-R2-mediated cellular responses to TNF-alpha by direct targeting of TNF-R2 for ubiquitination and proteasome-mediated degradation.
引用
收藏
页码:4716 / 4726
页数:11
相关论文
共 36 条
[1]   Tumor suppressor p16INK4A:: Determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4 [J].
Byeon, IJL ;
Li, JN ;
Ericson, K ;
Selby, TL ;
Tevelev, A ;
Kim, HJ ;
O'Maille, P ;
Tsai, MD .
MOLECULAR CELL, 1998, 1 (03) :421-431
[2]   Function and regulation of tumor necrosis factor receptor type 2 [J].
Carpentier, I ;
Coornaert, B ;
Beyaert, R .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (16) :2205-2212
[3]  
Chan FKM, 2000, EUR J IMMUNOL, V30, P652
[4]   TNF-R1 signaling: A beautiful pathway [J].
Chen, GQ ;
Goeddel, DV .
SCIENCE, 2002, 296 (5573) :1634-1635
[5]   A JNK-dependent pathway is required for TNFα-induced apoptosis [J].
Deng, YB ;
Ren, XY ;
Yang, L ;
Lin, YH ;
Wu, XW .
CELL, 2003, 115 (01) :61-70
[6]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[7]   Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation [J].
Frantsve, J ;
Schwaller, J ;
Sternberg, DW ;
Kutok, J ;
Gilliland, DG .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (10) :3547-3557
[8]   THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
GRELL, M ;
DOUNI, E ;
WAJANT, H ;
LOHDEN, M ;
CLAUSS, M ;
MAXEINER, B ;
GEORGOPOULOS, S ;
LESSLAUER, W ;
KOLLIAS, G ;
PFIZENMAIER, K ;
SCHEURICH, P .
CELL, 1995, 83 (05) :793-802
[9]   Transferring substrates to the 26S proteasome [J].
Hartmann-Petersen, R ;
Seeger, M ;
Gordon, C .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (01) :26-31
[10]   Ubiquitin-proteasome system - Proteins interacting with the 26S proteasome [J].
Hartmann-Petersen, R ;
Gordon, C .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (13) :1589-1595